Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 16;6(1):e12050. doi: 10.1002/trc2.12050

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Agents in clinical trials for treatment of Alzheimer's disease in 2020 (from ClinicalTrials.gov as of February 27, 2020. The inner ring shows Phase 3 agents; the middle ring is comprised of Phase 2 agents; the outer ring presents Phase 1 compounds; agents in green areas are biologics; agents in purple are disease‐modifying small molecules; agents in orange areas are symptomatic agents addressing cognitive enhancement or behavioral and neuropsychiatric symptoms; the shape of the icon shows the population of the trial; the icon color shows the class of target for the agent. Agents underlined are new to the pipeline since 2019 (Figure by Mike de la Flor)